Clinical Trials Browser

Extensive Stage Small Cell Lung Cancer × obinutuzumab × 90 days × Clear all

NCT07107490 2026-02-06

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

Phase 1 Recruiting

Extensive Stage Small Cell Lung Cancer